Page last updated: 2024-11-05

triamterene and Nephrocalcinosis

triamterene has been researched along with Nephrocalcinosis in 2 studies

Triamterene: A pteridinetriamine compound that inhibits SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS.
triamterene : Pteridine substituted at positions 2, 4 and 7 with amino groups and at position 6 with a phenyl group. A sodium channel blocker, it is used as a diuretic in the treatment of hypertension and oedema.

Nephrocalcinosis: A condition characterized by calcification of the renal tissue itself. It is usually seen in distal RENAL TUBULAR ACIDOSIS with calcium deposition in the DISTAL KIDNEY TUBULES and the surrounding interstitium. Nephrocalcinosis causes RENAL INSUFFICIENCY.

Research Excerpts

ExcerptRelevanceReference

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pierratos, A1
Couture, RA1
Hierlihy, PJ1
Bell, RC1
Levine, DZ1
Sörgel, F1
Ettinger, B1
Benet, LZ1

Other Studies

2 other studies available for triamterene and Nephrocalcinosis

ArticleYear
Bartter's syndrome, nephrocalcinosis and renal insufficiency.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1989, Nov-15, Volume: 141, Issue:10

    Topics: Adult; Bartter Syndrome; Creatinine; Female; Follow-Up Studies; Humans; Hyperaldosteronism; Kidney;

1989
Metabolic fate and solubility of triamterene--not an explanation for triamterene nephrolithiasis.
    Journal of pharmaceutical sciences, 1986, Volume: 75, Issue:2

    Topics: Adult; Buffers; Chromatography, Thin Layer; Humans; Hydrochlorothiazide; Hydrogen-Ion Concentration;

1986